Orbitech Co., Ltd. (KOSDAQ:046120)
6,270.00
0.00 (0.00%)
At close: Feb 19, 2026
Orbitech Revenue
Orbitech had revenue of 13.86B KRW in the quarter ending September 30, 2025, a decrease of -21.87%. This brings the company's revenue in the last twelve months to 58.25B, down -18.52% year-over-year. In the year 2024, Orbitech had annual revenue of 66.52B with 3.92% growth.
Revenue (ttm)
58.25B
Revenue Growth
-18.52%
P/S Ratio
3.28
Revenue / Employee
134.83M
Employees
432
Market Cap
191.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 66.52B | 2.51B | 3.92% |
| Dec 31, 2023 | 64.01B | 4.79B | 8.09% |
| Dec 31, 2022 | 59.22B | -18.96B | -24.25% |
| Dec 31, 2021 | 78.18B | 24.78B | 46.41% |
| Dec 31, 2020 | 53.40B | -21.55B | -28.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| K-Ensol | 506.57B |
| NEOWIZ HOLDINGS | 418.81B |
| TOPTEC | 214.82B |
| Keeps Biopharma | 157.75B |
| Dongbang Medical | 111.86B |
| HB SOLUTION | 96.23B |
| ILSEUNG | 53.34B |
| TOP MATERIAL | 39.65B |